| Product Code: ETC8978440 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Romania Pharmacogenetics Testing in Psychiatry/Depression Market Overview |
3.1 Romania Country Macro Economic Indicators |
3.2 Romania Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, 2021 & 2031F |
3.3 Romania Pharmacogenetics Testing in Psychiatry/Depression Market - Industry Life Cycle |
3.4 Romania Pharmacogenetics Testing in Psychiatry/Depression Market - Porter's Five Forces |
3.5 Romania Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Romania Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume Share, By Test Type, 2021 & 2031F |
3.7 Romania Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume Share, By Gene Type, 2021 & 2031F |
3.8 Romania Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume Share, By Patient Type, 2021 & 2031F |
3.9 Romania Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.10 Romania Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.11 Romania Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Romania Pharmacogenetics Testing in Psychiatry/Depression Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and acceptance of pharmacogenetics testing in psychiatry/depression in Romania |
4.2.2 Growing demand for personalized medicine and precision healthcare solutions |
4.2.3 Advancements in genetic testing technologies and research in the field of psychiatry and depression |
4.3 Market Restraints |
4.3.1 Limited reimbursement coverage for pharmacogenetics testing in Romania |
4.3.2 Regulatory challenges and lack of standardized guidelines for pharmacogenetics testing in psychiatry/depression |
4.3.3 High cost associated with genetic testing procedures |
5 Romania Pharmacogenetics Testing in Psychiatry/Depression Market Trends |
6 Romania Pharmacogenetics Testing in Psychiatry/Depression Market, By Types |
6.1 Romania Pharmacogenetics Testing in Psychiatry/Depression Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Romania Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Romania Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Anxiety, 2021- 2031F |
6.1.4 Romania Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Mood Disorders, 2021- 2031F |
6.1.5 Romania Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Depression, 2021- 2031F |
6.1.6 Romania Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Bipolar Disorders, 2021- 2031F |
6.1.7 Romania Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Psychotic Disorders, 2021- 2031F |
6.1.8 Romania Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Eating Disorders, 2021- 2031F |
6.2 Romania Pharmacogenetics Testing in Psychiatry/Depression Market, By Test Type |
6.2.1 Overview and Analysis |
6.2.2 Romania Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.2.3 Romania Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Chromosomal Array-Based Tests, 2021- 2031F |
6.3 Romania Pharmacogenetics Testing in Psychiatry/Depression Market, By Gene Type |
6.3.1 Overview and Analysis |
6.3.2 Romania Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By CYP2C19, 2021- 2031F |
6.3.3 Romania Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By CYP2C9 AND VKORC1, 2021- 2031F |
6.3.4 Romania Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By CYP2D6, 2021- 2031F |
6.3.5 Romania Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By HLA-B, 2021- 2031F |
6.3.6 Romania Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By HTR2A/C, 2021- 2031F |
6.3.7 Romania Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By HLA-A, 2021- 2031F |
6.4 Romania Pharmacogenetics Testing in Psychiatry/Depression Market, By Patient Type |
6.4.1 Overview and Analysis |
6.4.2 Romania Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Child, 2021- 2031F |
6.4.3 Romania Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Adult, 2021- 2031F |
6.4.4 Romania Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Geriatric, 2021- 2031F |
6.5 Romania Pharmacogenetics Testing in Psychiatry/Depression Market, By Product |
6.5.1 Overview and Analysis |
6.5.2 Romania Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Instruments, 2021- 2031F |
6.5.3 Romania Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Consumables, 2021- 2031F |
6.5.4 Romania Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Software & Services, 2021- 2031F |
6.6 Romania Pharmacogenetics Testing in Psychiatry/Depression Market, By End User |
6.6.1 Overview and Analysis |
6.6.2 Romania Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F |
6.6.3 Romania Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Dignostics Laboratories, 2021- 2031F |
6.6.4 Romania Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Academic And Research Institutes, 2021- 2031F |
6.6.5 Romania Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Others, 2021- 2031F |
6.7 Romania Pharmacogenetics Testing in Psychiatry/Depression Market, By Distribution Channel |
6.7.1 Overview and Analysis |
6.7.2 Romania Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Direct Tender, 2021- 2031F |
6.7.3 Romania Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Third-Party Distribution, 2021- 2031F |
6.7.4 Romania Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 Romania Pharmacogenetics Testing in Psychiatry/Depression Market Revenues & Volume, By Others, 2021- 2031F |
7 Romania Pharmacogenetics Testing in Psychiatry/Depression Market Import-Export Trade Statistics |
7.1 Romania Pharmacogenetics Testing in Psychiatry/Depression Market Export to Major Countries |
7.2 Romania Pharmacogenetics Testing in Psychiatry/Depression Market Imports from Major Countries |
8 Romania Pharmacogenetics Testing in Psychiatry/Depression Market Key Performance Indicators |
8.1 Adoption rate of pharmacogenetics testing in psychiatry/depression among healthcare providers in Romania |
8.2 Number of research studies and clinical trials incorporating pharmacogenetics testing in psychiatry/depression |
8.3 Patient satisfaction and outcomes improvement metrics post pharmacogenetics testing in psychiatry/depression |
8.4 Percentage of healthcare institutions offering pharmacogenetics testing in psychiatry/depression |
8.5 Integration of pharmacogenetics testing into treatment protocols and guidelines in psychiatry/depression practice in Romania |
9 Romania Pharmacogenetics Testing in Psychiatry/Depression Market - Opportunity Assessment |
9.1 Romania Pharmacogenetics Testing in Psychiatry/Depression Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Romania Pharmacogenetics Testing in Psychiatry/Depression Market Opportunity Assessment, By Test Type, 2021 & 2031F |
9.3 Romania Pharmacogenetics Testing in Psychiatry/Depression Market Opportunity Assessment, By Gene Type, 2021 & 2031F |
9.4 Romania Pharmacogenetics Testing in Psychiatry/Depression Market Opportunity Assessment, By Patient Type, 2021 & 2031F |
9.5 Romania Pharmacogenetics Testing in Psychiatry/Depression Market Opportunity Assessment, By Product, 2021 & 2031F |
9.6 Romania Pharmacogenetics Testing in Psychiatry/Depression Market Opportunity Assessment, By End User, 2021 & 2031F |
9.7 Romania Pharmacogenetics Testing in Psychiatry/Depression Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Romania Pharmacogenetics Testing in Psychiatry/Depression Market - Competitive Landscape |
10.1 Romania Pharmacogenetics Testing in Psychiatry/Depression Market Revenue Share, By Companies, 2024 |
10.2 Romania Pharmacogenetics Testing in Psychiatry/Depression Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here